Article
Mining drug-disease relationships as a complement to medical genetics-based drug repositioning: Where a recommendation system meets genome-wide association studies.
Clinical pharmacology and therapeutics - 1 May 2015
Wang H, Gu Q, Wei J, Cao Z, Liu Q
Abstract excerpt
A novel recommendation-based drug repositioning strategy is presented to simultaneously determine novel drug indications and side effects in one integrated framework. This strategy provides a complementary method to medical genetics-based drug repositioning, which reduces the occurrence of false positives in medical genetics-based drug repositioning, resulting in a ranked list of new candidate indications and/or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
